replication timing profiles are cell type-specific and reflect genome organization changes during differentiation. In this protocol, we describe how to analyze genome-wide replication timing (rt) in mammalian cells. asynchronously cycling cells are pulse labeled with the nucleotide analog 5-bromo-2-deoxyuridine (Brdu) and sorted into s-phase fractions on the basis of Dna content using flow cytometry. Brdu-labeled Dna from each fraction is immunoprecipitated, amplified, differentially labeled and co-hybridized to a whole-genome comparative genomic hybridization microarray, which is currently more cost effective than highthroughput sequencing and equally capable of resolving features at the biologically relevant level of tens to hundreds of kilobases. We also present a guide to analyzing the resulting data sets based on methods we use routinely. subjects include normalization, scaling and data quality measures, loess (local polynomial) smoothing of rt values, segmentation of data into domains and assignment of timing values to gene promoters. Finally, we cover clustering methods and means to relate changes in the replication program to gene expression and other genetic and epigenetic data sets. some experience with r or similar programming languages is assumed. all together, the protocol takes ~3 weeks per batch of samples.
IntroDuctIon
Although the mechanisms that specify the timing and placement of origin firing in higher eukaryotes remain a mystery, all eukaryotes have a defined RT program that is largely conserved between closely related species 1 , including humans and mice 2, 3 . Analyses of RT in various cell types have yielded insights into genome organization and repackaging events during development, suggesting an important role for the timing program itself or for 3D genome organization in regulating developmental gene expression 1, 3, 4 . In this protocol, we describe approaches for measuring genome-wide RT. As data processing and analysis often cause a bottleneck in these studies, the protocol also covers methods used routinely in our laboratory for downstream analysis 3, 5, 6 . Although this protocol emphasizes mammalian cells, as applied to analyze RT changes in various mouse and human cell types 3, 5, 6 , it can be adapted to any proliferating cell type; such variations have been used to analyze RT in Drosophila [7] [8] [9] , Arabidopsis 10 and budding yeast 11 .
Overview of the procedure: generating experimental data (Steps 1-61)
The first portion of the protocol describes how to derive raw data for genome-wide RT analysis. Given that the protocol measures the timing of events during the cell cycle, some form of synchronization is required. Synchronization can be achieved either prospectively, before cell collection, or retroactively, after the cells have been collected. In yeasts, prospective synchrony methods are well established, and in many cases, the same method can be used to compare different strains 12, 13 . However, most synchronization schemes for multicellular organisms are cumbersome and optimized for specific cell lines [14] [15] [16] , and most require the use of metabolic inhibitors that can interfere with normal regulation of replication 17, 18 . By contrast, retroactive synchronization using fluorescence-activated cell sorting (FACS) to select cells based on the increase in DNA content during S phase can be applied to any proliferating cell population without the need for any previous manipulation beyond dissociation of cells into a single-cell suspension 19 . Moreover, most prospective synchronization regimes for studying RT verify the quality of synchronization by FACS analysis of DNA content; as DNA content defines S-phase interval, selection of cells for DNA content is the most direct means to the desired end. The resolution of S-phase intervals is determined by the fineness of DNA content windows selected. The only situations in which prospective synchronization alternatives may need to be considered are for cells that are very difficult to dissociate or those that are severely aneuploid, such that DNA content does not reflect the time during S phase.
In the original method 20, 21 , cells were labeled with BrdU for a fraction of S-phase and sorted into several different time points during S-phase. BrdU-substituted DNA could then be isolated either on the basis of its increased density or by using BrdU-specific antibodies, and specific loci could be examined by hybridization or PCR [20] [21] [22] . With microarray analysis, replication of the entire genome can be queried in a single-array hybridization by limiting the analysis to two differentially labeled samples, allowing all probes to be assigned one internally normalized relative RT value and rapid comparison of many samples 3, 5, 6, 23, 24 . One limitation of assigning one RT value per map position is that it cannot distinguish cases in which homologous loci replicate asynchronously, a situation that is estimated to occur in a small percentage of the genome 19 . However, the protocol can be adapted for analysis of these genomic segments by dividing and sorting S-phase into finer fractions 19 . The two most popular variations of retroactive synchronization by FACS are described in PROCEDURE section below. In the first method, BrdU-labeled cells are divided into early and late S-phase fractions, and BrdU-labeled DNA synthesized either early or late can then be labeled and hybridized onto a microarray. This method produces a high signal-to-noise ratio, as immunoprecipitation (BrdU-IP) substantially enriches DNA synthesized in each half of S-phase. However, BrdU-IP efficacy can fluctuate and must Genome-scale analysis of replication timing: from bench to bioinformatics be closely monitored. In the second method, unlabeled cells are sorted into total S-phase versus G1-phase populations and DNA from these stages is differentially labeled and used as the target. This obviates BrdU-IP, but the dynamic range is limited to the twofold copy number increase during S-phase. Both methods yield similar results, evidenced by a direct comparison in the same cell line in one study 6 . In both methods, DNA from each fraction is differentially labeled with Cy3 and Cy5 dyes and then co-hybridized to a whole-genome oligonucleotide microarray. The ratio of the abundance of each probe in each fraction is then used to generate a RT profile.
Overview of the procedure: normalization and computational analysis of RT data sets (Steps 62-88)
In this section of the protocol, we focus on methods specifically useful for RT analysis using whole-genome comparative genomic hybridization (CGH) microarrays 25 , which we have used to investigate the type, degree and mechanism of RT changes in mouse and human cell lines 3, 5, 6, 23, 24 . General methods for normalizing and analyzing microarray experiments for chromatin modifications or transcription at gene promoters have been described in detail in other works [26] [27] [28] [29] . Similar to two-color microarray designs comparing an experimental sample with a reference, our RT experiments use a two-channel design comparing early versus late fraction enrichment for each target. Typically, we include two dye-swap replicates per sample to address bias due to dye-specific effects, such as more rapid photobleaching of Cy5 dye than Cy3. Our philosophy is to minimize the number of transformations applied to the data and apply only minimally invasive global methods for removing bias and scaling data sets to allow comparisons between them.
All the analysis described here uses the R framework for statistical computing [30] [31] [32] . Through user-submitted packages that facilitate a wide variety of methods, R has become an indispensible tool for many common computational tasks. Although R has an initially steep learning curve due to its command line interface, help is available in many locations and forms, including books [33] [34] [35] , online manuals (http://cran.r-project.org/) and mailing lists aggregated in the R mailing lists archive (http://tolstoy.newcastle.edu.au/R/). Help can also be found within R itself; the command str() is often helpful for viewing the structure of variables and data sets and the ? operator (e.g., ?data.frame() ) provides a help page for the corresponding function. We use the R package LIMMA (linear models for microarray data), also available with a user interface through the limmaGUI package, for normalization and scaling 27, 36 . The steps for this process are straightforward and are illustrated using two biological replicate data sets of mouse L1210 lymphoblast cells; these data sets are available in raw form in Supplementary Data 1-4, and after normalization and smoothing at http://www. ReplicationDomain.org/.
We provide this section as a verified route for extracting information from the microarray experiments described in the PROCEDURE; however, users with sufficient experience with R or having different requirements for their data are free to modify the analysis as needed, and a wide array of alternative and additional methods are available through Bioconductor 31 . Although our methods for downstream analyses were tested primarily with NimbleGen CGH microarrays, most are applicable to any data format containing chromosome, genomic position and RT information for each probe.
Experimental design BrdU incorporation. The nucleotide analog BrdU can be used to pulse-label newly synthesized DNA during the S-phase. For mammalian cell types that have 8-to 12-h S-phases, incubation with BrdU for 2 h has been empirically determined to provide sufficient incorporation to ensure successful BrdU-IP in subsequent steps, yet the incubation time is long enough to identify even subtle differences in RT, such as between female cells with one versus two early replicating X chromosomes 5 . Success has also been achieved with BrdU labeling times as short as 1 h, but subsequent BrdU-IP can be problematic, as there is very little substituted DNA relative to the background of unsubstituted DNA that will contribute to noise in the BrdU-IP 6 . The BrdU-labeling times for cells with S-phase lengths substantially different from mammalian cells, such as amphibian 20 or fly 8 cells, should be adjusted appropriately.
FACS sorting fractions of S-phase. For first-time users, we recommend that at least 5 × 10 6 cells be used; however, with experience and a sufficient fraction of S-phase cells, fewer than 0.5 × 10 6 starting cells can be successfully profiled. The important parameter is to obtain 20,000-30,000 cells in each of the early and late S-phase fractions. As described in PROCEDURE Step 1A, ethanol-fixed cells can be stained with propidium iodide (PI) and sorted on the basis of DNA content. Alternative fluorochromes that do not require RNase digestion, such as chromomycin A3, can also be used with ethanol-fixed cells 20, 21 . Some cell types tend to clump or produce a lot of cellular debris when fixed in ethanol. For these cell types, the fixation step can be skipped and DNA can be stained with DAPI (4,6-diamidino-2-phenylindole) in permeabilized cells, as described in PROCEDURE Step 1B. The advantage of the method described in Step 1A is that cells fixed in ethanol can be stored at − 20 °C (empirically determined to be the optimal temperature) or shipped to collaborators. The cells should be placed on dry ice during shipping, with a partition between the tube and the dry ice to prevent cell freezing. All steps, particularly storage, should be done in the dark, as BrdU-substituted DNA is light sensitive.
During FACS analysis, forward and side scatter analyses should be used to select an appropriate population of cells free of doublets or cell debris, both of which can hinder accurate sorting of desired populations. Lasers used in this protocol include 488-nm blue to detect PI or 407-nm violet to detect DAPI in cells that have been stained for DNA content. Two separate fractions of S-phase, early and late, are typically chosen for collection, but more can be collected if desired 20, 21 .
Immunoprecipitation of BrdU-labeled DNA. DNA from BrdUlabeled cells should be sonicated into fragments ranging from 250 bp to 2 kb and then immunoprecipitated using a BrdU-specific antibody. Sonication into fragments of this size helps eliminate IP of DNA that has not been labeled with BrdU. If samples have been stored at − 20 °C before beginning the IP, thaw them in a 56 °C water bath to completely dissolve SDS, and then add 200 µl of SDS-PK buffer, prewarmed to 56 °C with 0.05 mg ml − 1 glycogen, to each sample before performing the phenol-chloroform extraction in PROCEDURE Step 13.
Quality control check of S-phase DNA. Because of the sensitivity and large number of steps involved, BrdU-IP is one of the trickiest parts of the protocol. To ensure quality, screen BrdU-IPs by PCR amplification, using primers specific to DNA markers of known relative replication time (i.e., early or late phase). Although real-time PCR can be performed, we find gel electrophoresis to be sufficient to evaluate enrichment of DNA in each IP sample. Importantly, as PCR results can vary between aliquots of the same sample and RT can vary between cell types 3, 5 , consistency across multiple samples from the same cell type is the best way to verify quality. Use the primer sets listed in Table 1 for mouse or human cell types, or substitute suitable alternatives to screen several IPs from both early and late S-phase fractions.
Amplification methods for immunoprecipitated single-stranded DNA. Once purified by IP and screened for sample quality, BrdUincorporated DNA must be amplified to obtain sufficient amounts for array hybridization. If multiple samples pass PCR screening, pool DNA from parallel IPs to use as the starting material for whole-genome amplification (WGA); otherwise, use a single-screen IP. Perform WGA as desired (we use the GenomePlex Complete Whole Genome Amplification and Reamplification Kits from Sigma), load amplified samples onto a gel to determine size range and screen once more by PCR to ensure that no bias was introduced during amplification.
Labeling and hybridization of amplified samples. The specific steps required in this section will largely depend on the chosen array platform. Although we focus on NimbleGen products to avoid the ambiguity inherent to generalized methods, the products can be applied successfully to other platforms 8, 9 , including deep sequencing of BrdU-IP DNA 37 . Currently, mammalian RT data generated from microarray hybridization and deep sequencing are of equal quality 3, 6 , whereas the microarray method remains more cost effective and the bioinformatics are considerably less demanding for the typical laboratory. Future advances reducing BrdU-labeling times and sequencing limitations may make this method more cost effective and accessible 38 . Once a platform is chosen, the labeling and hybridization steps are fairly straightforward. Briefly, 1 µg of early or late replicating DNA may be labeled with either Cy5 or Cy3 random 9-mer dyes by Klenow reaction, precipitated with isopropanol and resuspended and quantified in nuclease-free water. Finally, equal quantities of labeled early-and late-fraction DNA should be combined (specific quantity will depend on array design).
Array design. Array design is also an important consideration, and the nature of your study should be a guide in selecting between the variety of available standard and custom designs. For our genomewide studies in both mouse and human cell lines, 385K-and 3 × 720K-feature CGH tiling arrays have sufficient probe densities, showing no disadvantage compared with high-density 2.1M CGH tiling arrays 5, 6 , but they have considerable cost and convenience advantages. Tiling designs with roughly evenly spaced probes also facilitate the interpretation and analysis of genetic features.
Array scanning. Carry out scanning according to the manufacturer's recommendations, avoiding unnecessary laser exposure. Take care to align channels with respect to signal intensity frequencies, although minor differences between channels usually do not impact smoothed timing profiles after normalization.
Quality control of microarray data. Before analysis, the overall quality of a microarray experiment should be examined from several angles. In general, there are six qualities that are important for reliable results of RT analyses on CGH arrays that should be verified at the corresponding PROCEDURE steps:
(1) Comparable signal intensity distributions for red and green channels (Step 74). 
Downstream analysis.
When comparing the timing program with other genetic and epigenetic properties, you should note that differences in formats between chromatin immunoprecipitation (ChIP)-on-chip, ChIP-seq and other approaches will require some care in processing, and even data sets from similar platforms often have idiosyncrasies that must be accounted for. In particular, take care to ensure that RT and other data types are compared in compatible genomic builds and equivalent cell types; use a method of quantification consistent with the methods and goals of the studies involved. ) To prepare 20 ml, dissolve 20 mg PI powder in autoclaved ddH 2 O to obtain a final volume of 20 ml and filter by syringe. Store protected from light for up to 1 year at 4 °C. DAPI staining solution To prepare ~1 ml, add 10 µl of 10% (vol/vol) Triton X-100 and 2 µl of 1 mg ml − 1 DAPI to 1 ml of PBS. Prepare the solution fresh before each use. BrdU-specific antibody (12.5 µg ml • Phenol-chloroform solution To prepare 50 ml, combine 25 ml of Tris-saturated phenol with 25 ml of chloroform. Allow separation of layers before use. We recommend that the solution be stored overnight before use to allow adequate separation or centrifuged at maximum speed for 10 min before use to achieve separation. Store at 4 °C protected from light. SDS-PK buffer To prepare 50 ml, combine 34 ml autoclaved ddH 2 O, 2.5 ml of 1 M Tris-HCl (pH 8.0), 1 ml of 0.5 M EDTA, 10 ml of 5 M NaCl and 2.5 ml of 10% (wt/vol) SDS. Store at room temperature. Warm to 56 °C before use to completely dissolve SDS. IP buffer (10×) To prepare 50 ml, combine 28.5 ml of ddH 2 O, 5 ml of 1 M sodium phosphate (pH 7.0), 14 ml of 5 M NaCl and 2.5 ml of 10% (wt/vol) Triton X-100. Store at room temperature. IP buffer (1×) To prepare 50 ml, add 5 ml of 10× IP buffer to 45 ml of autoclaved ddH 2 O. Store at room temperature. Digestion buffer To prepare 50 ml, combine 44 ml of autoclaved ddH 2 O, 2.5 ml of 1 M Tris-HCl (pH 8.0), 1 ml of 0.5 M EDTA and 2.5 ml of 10% (wt/vol) SDS. Store at room temperature. EQUIPMENT SETUP Sonicator Adjust sonicator settings as needed to achieve a 250 bp to 2 kb distribution of DNA fragment sizes. We use a water bath-type sonicator (Heat Systems-Ultrasonics W-380) with a 2-s, 50% duty cycle and an output setting of 7 for 4 min.
MaterIals

REAGENTS
proceDure Brdu labeling and staining of cells for Facs 1| To perform PI staining and ethanol fixation before sorting, follow option A; this method is most commonly used, as it allows for shipping or long-term storage, and it has worked well for most mouse cell lines 5, 6 . For cells that break or clump in ethanol, follow option B; note that a drawback of option B is that cells need to be sorted immediately following BrdU labeling. Alternatively, carry out the procedure for S/G1 sorting described in Box 1 instead of Steps 1-57 (see also Fig. 1 ). This method obviates the need for BrdU-IP and WGA and can alleviate concerns that sorting early and late fractions of S-phase or WGA introduce a temporal bias; however, in our experiments, E/L (early/late) fractionation has produced results equivalent to the S/G1 method as well as sorting of additional S-phase fractions 3, 37 . 
Box 1 | METHoD FoR SoRTING ACCoRDING To S/G1-PHASE • tIMInG 1 D
In this method, cells are sorted into two fractions, G1-and S-phase, based on DNA content, and RT is derived from the twofold copy number increase for early versus late replicating sequences in pure S-phase populations. DNA analysis using flow cytometry can be performed simply by the use of a single DNA-binding fluorescent dye, such as PI or DAPI, as originally described 59 . Although this method is adequate, simultaneous measurement of BrdU-labeled DNA by performing BrdU/PI double staining for cell cycle analysis can discriminate G1-and early S-phase cells much more efficiently than by PI-only staining. In addition, some cell types, particularly those derived from differentiated stem cells or primary tissues, can produce debris that interferes with good S-phase sorting, and a short BrdU label described here can eliminate debris that is not labeled with BrdU. The advantage of this method is that it eliminates the need for BrdU-IP and WGA steps (described in Steps 13-44 and 51-57), which need to be carefully controlled. However, direct comparisons have shown that this method produces a lower signal-to-noise ratio than the method described in the main PROCEDURE 6 . A much shorter BrdU pulse label is used in this protocol at lower concentration, because we are only trying to identify the cells in S-phase. With longer BrdU-labeling time periods, G2/M cells become labeled. It should be noted that we originally used the standard protocol for BrdU/PI analysis provided by Becton-Dickinson, which is fine for analysis. However, we found that the high concentration of HCl in this method sheared genomic DNA to very small fragments that precluded subsequent steps of the protocol. By titrating HCl, we found that 0.1 M HCl produced the optimal compromise between good S-versus G1-phase separation and minimal DNA shearing. For BrdU/PI double-staining, correction of spectral overlap is critical for successful experiments. Spectral overlap exists between emission spectra of PI and fluorescein isothiocyanate (FITC)/Alexa Fluor 488 (for BrdU). Without correction, the BrdU/PI plots typically look similar to Figure 1a . For this correction, the adjustment of the ratio between PI and Alexa Fluor 488 (or FITC) gains can significantly reduce the skewing shown in Figure 1a . Subtraction of the FITC signal from the PI signal (i.e., compensation) may also be required. To perform these corrections, a 'BrdU-only' control is required, prepared by staining BrdU-labeled cells without the addition of PI. A 'PI-only' control also helps, prepared by staining non-BrdU-labeled cells for BrdU and PI. (Note: BrdU-labeled specimen stained for PI only does not reflect background signals derived from the anti-BrdU antibody and thus is not as good as unlabeled cells.) This step can be time-consuming, but is critical for successful sorting. We suggest that you first adjust the gains of forward scatter and side scatter, and then adjust the PI and AlexaFluor488 gains by trial and error to obtain the best possible BrdU/PI plot. You may be able to obtain a reasonable BrdU/PI plot without compensation; otherwise, compensate by subtracting FITC signal from PI signal. The lower the percentage subtracted, the better. s/G1 Facs sorting • tIMInG 1 d 1. For adherent cells, remove cell culture medium from exponentially growing cells and replace with cell culture medium containing BrdU at a final concentration of 10 µM. For suspension cells, add BrdU to the cell culture medium at a final concentration of 10 µM. In order to obviate the amplification step before labeling and array hybridization, start with 6 million cells. One should also prepare a small sample of non-BrdU-labeled, ethanol-fixed cells for PI-only control and set aside a small number of BrdU-labeled cells for BrdU-only control. 2. Incubate cells for 15 min in a CO 2 incubator at 37 °C and 5% CO 2 . 3. Fix as described in Steps 1A(iii-x) of the main PROCEDURE.
 pause poInt Cells can be stored as in Step 1A. 4 . Aliquot (multiples of) 3 × 10 6 cells in 1.5-ml tube(s), centrifuge for 5 min at 200g at room temperature. Removal of supernatant is much easier with 1.5-ml tubes as the pellets are very loose. 5. Aspirate the supernatant completely with a P200 pipette. Here and elsewhere, an additional pulse spin (~3 s) will help with discarding residual supernatant. 6. Loosen the pellet by brief vortexing. 7. Add 1 ml of 0.1 M HCl/0.5% (vol/vol) Triton X-100; resuspend by tapping. 8. Incubate for 15 min at room temperature in the dark. 
2|
Run the sample on FACSAria cell sorter (alternatively, any comparable cell sorter can be used).  crItIcal step It is very important to place live samples chilled on ice or at 4 °C during FACS analysis to avoid cell-cycle progression in the absence of BrdU. Protect samples from light.
3|
Use forward and side scatter information to select the desired population of cells to be included in the sort, and exclude doublets or cell debris.
4|
Create a histogram that plots cell count on the y axis and DNA content (fluorochrome intensity) on the x axis (see Fig. 2 ).
5| Select two distinct S-phase populations to be sorted into separate fractions, as indicated in 7| Centrifuge at 400g for 10 min at 4 °C. Alternatively, if fewer than 150,000 cells have been collected for each fraction, proceed directly to Step 9.
8| Decant supernatant gently, only once.  crItIcal step Some residual sheath fluid can be left in the tube to prevent losing the cell pellet, which can easily detach from the tube during this step.
9| Add 1 ml of SDS-PK buffer containing 0.2 mg ml − 1 of proteinase K and 0.05 mg ml − 1 of glycogen for every 100,000 cells collected and mix vigorously by tapping the tube. 
31|
Remove the supernatant completely.  crItIcal step If the pellet becomes loose, then briefly centrifuge the sample again in order to completely remove the supernatant without disturbing the pellet. Several centrifugations may be necessary to completely remove the supernatant.
32|
Add 750 µl of 1× IP buffer that has been chilled on ice.
33| Centrifuge at 16,000g for 5 min at 4 °C.
34|
Remove supernatant completely, as in Step 31.
35|
Resuspend the pellet in 200 µl of digestion buffer with freshly added 0.25 mg ml − 1 proteinase K. Incubate the samples overnight at 37 °C.
36|
Add 100 µl of fresh digestion buffer with freshly added 0.25 mg ml − 1 proteinase K.
37|
Incubate the samples for 60 min at 56 °C.
38|
Extract once with phenol-chloroform, collecting the upper phase in a 1.5-ml tube.
39|
Extract once with chloroform, collecting the upper phase in a 1.5-ml tube. 
40|
Whole-genome amplification • tIMInG 8 h 51|
Precipitate DNA fractions by adding 1.25 µl of 2 mg ml − 1 glycogen, 20 µl of 10 M ammonium acetate and 150 µl of ethanol to each 50-µl IP sample (if pooling multiple samples, a total volume of 50 µl should still be used). Mix well, let it stand at − 20 °C for 20 min and then centrifuge for 30 min at maximum speed at 4 °C.
52|
Rinse the pellets with 70% (vol/vol) ethanol, air-dry them, and then resuspend them in 10 µl of nuclease-free water.
53|
Transfer the 10-µl samples to 0.2-ml PCR tubes and carry out WGA using an appropriate method or kit. In our experiments, the GenomePlex Complete Whole Genome Amplification Kit has worked well, starting from the library preparation step (i.e., skipping fragmentation) 39 .
54| Purify entire WGA products using an appropriate PCR purification kit, such as QIAquick. Elute in 30 µl nuclease-free water prewarmed to 65 °C and determine the concentration using Nanodrop.
55|
Dilute WGA samples to appropriate concentration (we use 1 µl DNA of 20 ng µl
) and, if necessary to obtain sufficient material for the chosen array platform, perform a second round of WGA. We follow the GenomePlex WGA Reamplification Kit, Reamplification Procedure A.
56|
Purify entire reamplified WGA products as in Step 54.
57|
Screen purified final products using the PCR method described in Steps 46-49.  pause poInt Samples can be stored in the dark at − 20 °C for up to 1 month. ? trouBlesHootInG labeling and hybridizing • tIMInG 1-3 d 58| Differentially label reamplified early and late WGA DNA fractions with Cy3 and Cy5 dyes from Step 57 (or nonamplified DNA prepared as in Box 1) according to the method most appropriate for the chosen array platform. We follow the sample labeling instructions for the NimbleGen Dual-Color DNA Labeling Kit.
59|
Hybridize the samples to array(s) using the corresponding method or kit. We use the NimbleGen Hybridization Kit.
60|
After hybridization, wash array(s) as needed. We perform this step, according to the manufacturer's instructions, using the NimbleGen Wash Buffer Kit.
61| Scan array(s) with an appropriate microarray scanner and software package. We use the NimbleGen scanner GenePix 4000B and the accompanying NimbleGen arrays user's guide, CGH analysis v5.1. Newer equipment is accompanied with a newer version of the user's guide and operated slightly differently. For NimbleGen arrays, raw images should be saved as .tif files, and two .pair files (one each for Cy3 and Cy5 channels) will be created per experiment. normalization of raw data sets • tIMInG 1 d 62| If necessary, install R from http://www.r-project.org/. Create RGL (Red Green List) files from the original NimbleGen .pair files, as described in Steps 63-68. These files contain columns for both red (Cy5) and green (Cy3) channel signal intensities; example pair files used in Step 65 and throughout are available in supplementary Data 1-4. 63| Set the working directory using the command 'setwd' in the R console to specify the appropriate file path. Here and in later steps, the ' > ' symbol denotes the R prompt at the beginning of a line and should be omitted when typing the command.
> setwd(″D:\RT project\Raw datasets″)
64| Read the first five rows of data from the raw data files and determine the data type of each column using the sapply() function: > tab5rows < - read.delim(″318990_4L1210LymphoblastP1_532.pair″, header = T, nrows = 5, skip = 1) > classes < - sapply(tab5rows, class)  crItIcal step When reading large tables in R, such as .pair files, explicitly noting the number of rows and data type of each column as illustrated here and in Step 65 will save a substantial amount of memory and calculation time. Occasionally, the sapply() function will set the genomic position columns of large data sets as an integer type, which lacks the memory space to store large numbers. If so, set the type manually with > classes[x] = 'numeric' (where x is the column number containing position information) after creating the classes variable.
65|
Read the raw data sets into memory. Note that variable names and file names may be substituted here and elsewhere, as appropriate. The 'nrows' parameter can be a modest overestimate; the correct number of rows will be present in the final table, but an estimate allows the system to allocate the correct amount of memory. 
67| Write the columns extracted in
Step 66 to separate RGL files for normalization > write.table(mLymph1, file = ″L1210LymphoblastR1.rgl.txt″, row.names = F, quote = F, sep = ″\t″, eol = ″\r\n″) write.table(mLymph2, file = ″L1210LymphoblastR2.rgl.txt″, row.names = F, quote = F, sep = ″\t″, eol = ″\r\n″) 68| Create a 'targets' text file that describes the target files for normalization. We will name this file 'T.txt' (see supplementary Data 5 for an example targets file). Note that, to be read correctly, the file should be tab delimited and should contain only one carriage return at the end of the final line. Place this file in the same directory as the raw .pair files and .rgl files generated above.
69|
Install a current version of the LIMMA package according to the instructions at http://bioinf.wehi.edu.au/limma/ or by using the command line interface:
> source(″http://www.bioconductor.org/biocLite.R″) > biocLite(″limma″) > biocLite(″statmod″) 70| Perform LOESS and scale normalization using LIMMA as described in Steps 71-73 and verify the results as described in Steps 74-85. This process is more straightforward than many two-color normalization methods, as NimbleGen arrays do not have print tip groups, spot background areas or mismatch spots that must be accounted for. LOESS normalization ( normalize within arrays) corrects the internal dependence of red-green ratios on their intensity independently for each array and is examined further in Steps 74 and 75. Scale normalization (normalize between arrays) equalizes the distribution of timing values between multiple samples for comparisons and can be verified in Step 76.
71|
Load the LIMMA package and read the raw data sets listed in the file created in Step 68. This will generate a MAlist-type data object, r, which stores the ratios (M-values) and average intensity values (A-values) of raw samples before normalization:
> library(limma) > t = readTargets(″T.txt″, row.names = ″Name″) > r = read.maimages(t, source = ″generic″,columns = list(R = ″S_Cy5″, G = ″S_Cy3″)) 72| Perform LOESS normalization. This will generate a second MAlist-type data object, MA.l, which stores the samples after within-array normalization.
> MA.l = normalizeWithinArrays(r, method = ″loess″) 73| Perform scale normalization. This will generate a third MAList object, MA.q, which stores the samples after betweenarray normalization. As with ChIP-chip methods 13, 14 , this type of scale normalization may not be appropriate for examining subsets of the genome in which large unbalanced timing changes are expected (e.g., timing of the X chromosome before and after inactivation), but is ideal for whole-genome analyses.
> MA.q = normalizeBetweenArrays(MA.l, method = ″scale″) 74| Check the distribution of spot intensities for red and green channels after each stage of normalization (Fig. 3) . These distributions should be fairly well aligned and should have tails with high signal values. Experiments in which signal intensity drops off more sharply will often show higher levels of noise in the final data set. (Here and in subsequent steps, text following the '#' symbol represents non-executed comments.) > plotDensities(r) # Raw data > plotDensities(MA.l) # After within-array normalization > plotDensities(MA.q) # After between-array normalization 75| Create MA plots to check for a relationship between the ratio of dye intensities (M) and their average (A) (Fig. 4) . Points will often be skewed to low Cy5/Cy3 ratios at low intensities due to photobleaching of Cy5, but should be corrected after within-array loess normalization in LIMMA. This bias is the most common artifact for NimbleGen arrays but other types can also be diagnosed with MA plots 40 .
> plotMA(r, array = 1) # Raw data, replicate 1 > plotMA(MA.l, array = 1) # After within-array normalization
76|
Verify that the distribution RT values are equivalent across experiments after normalization by creating boxplots of Cy5/Cy3 ratios for each experiment (Fig. 5) . These distributions may be slightly different before normalization (and after within-array normalization), but first and third quartiles (the box boundaries) of all experiments should be equal after between-array normalization. This tab-delimited text file will be further processed in Steps 79-85 to sort and average the normalized data sets and check other quality control measures.
78|
Remove the other objects from memory.
> rm(r, MA.l, MA.q, mLymph1Cy3, mLymph1Cy5, mLymph2Cy3, mLymph2Cy5, mLymph1, mLymph2); gc(reset = T) Or, remove all objects.
> rm(list = ls())
79| Assign position and chromosome information to the normalized data sets. This can be accomplished using the original .pair files, which typically contain this information in columns 'POSITION' and 'SEQ_ID', respectively (option A). Some data formats, such as HD2 triplex arrays, contain a different format of SEQ_ID column with chromosome and chromosome end points combined (e.g., 'chr11:1-134452384') or no SEQ_ID column. In these cases, extract chromosome labels from the PROBE_ID column (option B) 80| Sort data sets by chromosome and position. This will ensure that the plotting and autocorrelation checks in Steps 81 and 84 are accurate and that they are required for most downstream analysis. By the default sorting method, the order of mouse chromosomes will be 1, 10-19, 2-9, X and then Y. This order itself is unimportant but should be consistent across experiments to prevent errors in downstream analysis.
> RT = RT[order(RT$CHR, RT$POSITION),]
81|
Plot timing values across a chromosome (Fig. 6) . This serves to verify the orientation for early/late domains, as well as the overall technical quality of the experiments. Check the data set structure using 'str(RT)' for the correct column numbers to plot and adjust the y axis span ('ylim') as needed. 
84|
For each data set, determine the autocorrelation function (ACF), which describes the correlation between neighboring data points as a function of their genomic distance (Fig. 7) . As nearby loci should replicate almost synchronously, the ACF is a useful measure of overall data quality. Highquality data sets will have a correlation between nearest neighbor timing values of R = 0.60-0.80. This measure of signal-to-noise ratio will improve as more replicates with equivalent states are averaged. 
85|
To check for spatial artifacts, examine the original .tif images (Fig. 8) for common characteristics of regional bias, such as streaks, blank regions or overabundance of either channel in any region of the array 41 . Note that the 'rtiff' package may first need to be installed as in Step 72. As most probes on tiling microarray designs are randomly distributed with respect to genomic location, spatial artifacts in the scanned images should not affect timing values to a large extent in any particular location in the genome, but may reduce the overall signal-to-noise ratio of the experiment if they cover a substantial portion of the array. Although optional, each method is complementary and useful for a wide range of downstream analysis. To derive an overall timing profile from noisier raw data points, apply a loess smoothing function (option A). Use a correlation metric, generally after LOESS smoothing, to determine the overall levels of similarity among two or more data sets (option B). Perform segmentation (option C) to define the boundaries of replication domains and determine their average timing.
(a) loess smoothing (i) Apply LOESS smoothing to each chromosome as outlined below (Fig. 9) . For human and mouse data sets, we perform smoothing with a bandwidth of 300 kb; other systems may have different optimal smoothing spans that should be determined empirically using the smallest span that reproduces most of the features between replicate profiles. (Fig. 9) . The ″mfrow″ parameter may be adjusted for different numbers of data sets. The cor() function defaults to Pearson correlation, but other methods are available (see ?cor in R). If missing values are present, add 'na.rm = T' to remove them. (c) segmentation (i) Perform circular binary segmentation as outlined in Steps 86C(ii-iv) (Fig. 10) . Biologically, these segments (or 'replication domains') appear to correspond to domains of coordinately regulated, synchronously firing origins that may be part of replication factories. We perform segmentation as follows using the DNACopy algorithm designed by Venkatraman et al. 42 , which performs favorably compared with alternatives for CGH copy number analysis [43] [44] [45] . (ii) First, load the DNAcopy package and prepare a CNA (copy number array) object for segmentation > library(DNAcopy) > mLymph = CNA(RT$mLymphAve, RT$CHR, RT$POSITION, data.type = ″logratio″, sampleid = ″mLymph″) (iii) Next, segment the CNA object with the desired parameters. The parameters shown are those that we have used for analysis of mouse and human timing data sets, with autocorrelations near 0.8 3, 6 ; data of different quality or in different formats may require these to be determined empirically.
> Seg.mLymph = segment(mLymph, nperm = 10000, alpha = 1e-15, undo.splits = ″sdundo″, undo.SD = 1.5, verbose = 2) (iv) Examine the resulting segmentation object 'Seg.mLymph', which contains the raw data and segmentation breakpoints assigned by circular binary segmentation 46 . The number of segments assigned can be determined using str(Seg.mLymph$output) and visualized using various functions built into DNAcopy (Fig. 10) . (a) percentage change analysis (i) Determine the amount of the genome with differential timing between two or more cell types using an arbitrary, percentile or significance-based cutoff for RT changes. We recommend scaling data sets to equivalent ranges and applying an empirical cutoff for changes verifiable by PCR to quantify these genome wide, as shown here. As most methods for quantifying timing changes are sensitive to scale differences, data sets should be first scaled and normalized together in LIMMA (see Steps 62-76). (i) Perform segmentation on the differences between timing profiles to define the boundaries of domains that switch to earlier or later replication (switching domains) and analyze the properties of genetic and epigenetic elements within them. To compute these domains, first subtract the normalized (not LOESS-smoothed) values of the two experiments to be compared and create a CNA object in a manner similar to Step 86C(ii).
> dRT = CNA(RT$NPCave-RT$ESCave, RT$CHR, RT$POSITION, data.type = ″logratio″, sampleid = ″NPC-ESC dRT″) (ii) Next, segment the resulting object, calculate domain sizes and write the segments to a tab-delimited text file.
> Seg.dRT = segment(dRT, nperm = 10000, alpha = 1e-15, undo.splits = ″sdundo″, undo. SD = 1.5, verbose = 2); dRTdom = Seg.dRT$output > dRTdom$size = dRTdom$loc.end - dRTdom$loc.start > write. 
antIcIpateD results
Our research has shown that the described method is a powerful tool for genome-scale analysis of RT. However, meaningful data analysis is dependent on the quality of available data. Therefore, measures should be taken throughout the protocol to ensure that each phase of the procedure produces quality starting material for subsequent phases. Anticipated results for various steps of the protocol are described here. Typical FACS plots showing successful DNA content analysis and indicating appropriate S-phase fractions to be collected are shown in Figure 1 .
Following cell sorting and BrdU-IP, marker genes with known relative RT (table 1) should be amplified by PCR for multiple IP samples and detected by electrophoresis on an agarose gel. Among the mouse sequences listed in table 1, mitochondrial DNA replicates throughout the cell cycle 58 and will typically be equally represented in early and late S-phase fractions. Hba-a1, Pou5f1 and Mmp15 are generally early replicating markers, whereas Hbb-b1, Zfp42, Dppa2, Ptn, Mash1 and Akt3 are generally late replicating markers. Note that some genes switch RT at some point during development; for instance, Zfp42 and Dppa2 are early replicating in ESCs, but late replicating in all somatic cell types examined to date. Therefore, consistency across multiple samples from the same cell type is usually the most reliable way to assess the quality of IP samples. Among the human sequences listed in table 1, mitochondrial DNA is equally represented in early and late S-phase fractions, whereas HBA1, MMP15 and BMP1 are generally early replicating markers. PTGS2, NETO1, SLITRK6, ZFP42 and DPPA2 are generally late replicating. High-quality IP reactions show consistency in the relative amount of BrdU-labeled DNA in respective S-phase fractions between samples of the same cell type. This PCR analysis should be performed again directly following WGA in order to ensure that no bias has been introduced during this step of the procedure. If no bias is detected, 4-8 µl of purified WGA3 DNA should be run on a 1.5% agarose gel in order to determine its quality. Quality DNA will range in size from 100 to 1,000 bp, with an average size of ~400bp. Sensitivity of segmentation algorithms to differences in data quality
Either adjust the parameter undo.SD (using similar autocorrelation-level data sets as a guide) or add Gaussian noise to higher-quality data sets to equalize their ACF (Step 84) before segmentation in order to function as high-quality starting material for the labeling reaction. NimbleGen arrays user 's guide for CGH analysis should be consulted for anticipated results of the hybridization and scanning procedures. After a successful experiment, domains of coordinate RT (replication domains) will be clearly visible in the raw data after plotting these across a chromosome (Fig. 6) . Less-successful experiments will have autocorrelation values below 0.6 (Fig. 7) , and visibly higher levels of noise, thereby limiting the resolution of smaller replication domains. Further, low signal in MA plots (Fig. 4) and signal intensity distributions (Fig. 3) will also often present with low autocorrelation, and may indicate a low volume of Cy-labeled DNA or problems with scanning. If several replicate experiments were done, they should have high ( > 0.90) correlations between LOESS-smoothed timing values (Step 86B). 
